Auricular vagus nerve activation suppresses allergic airway inflammation via TRPV1+ afferents and CGRPβ
Background
Current therapies for allergic asthma and other airway inflammatory diseases often fall short, leaving a significant unmet need. The vagus nerve is a known regulator of inflammation through internal (interoceptive) signals. However, the potential for external (exteroceptive) inputs, particularly from the skin, to modulate visceral neuroimmune responses remains largely unexplored. This study investigates a novel skin-lung reflex, aiming to uncover how external sensory stimulation could impact internal airway inflammation.
Study Design
Researchers established an Alternaria alternata-induced allergic airway inflammation model in mice. They used viral and chemical neural tracing to map sensory projections from vagal ganglia to auricular skin. To modulate neural activity, they employed pharmacologic, chemogenetic, and optogenetic methods to activate or silence auricular transient receptor potential vanilloid 1 (TRPV1)+ afferents. Primary endpoints included assessing type 2 allergic lung inflammation, specifically quantifying group 2 innate lymphoid cell (ILC2), eosinophil, and type 2 cytokine responses in the airway, comparing activated vs. silenced afferent groups and controls.
Results
Activation of auricular TRPV1+ afferents significantly attenuated type 2 allergic lung inflammation. This suppression included a marked reduction in group 2 innate lymphoid cell (ILC2), eosinophil, and type 2 cytokine responses within the airway. Conversely, when these specific sensory neurons were silenced via the skin, lung inflammation was exacerbated, highlighting their critical role in modulating the immune response. The observed immunosuppression of airway inflammation was found to be explicitly dependent on the neuropeptide calcitonin gene-related peptide (CGRP)β. This establishes a clear neuroimmune pathway. > This study unveiled an evolutionarily conserved somato-visceral reflex where exteroceptive inputs from the auricular skin directly impact visceral inflammation in the lungs.
Key Findings
- Auricular vagal sensory neurons project to the auricular skin, forming a skin-lung reflex.
- Activation of auricular
TRPV1+afferents attenuated type 2 allergic lung inflammation. - Suppression included reduced
ILC2, eosinophil, and type 2 cytokine responses in the airway. - Silencing these afferents exacerbated lung inflammation, confirming their anti-inflammatory role.
- Immunosuppression was dependent on the neuropeptide calcitonin gene-related peptide (CGRP)β.
Why It Matters
This research opens a promising avenue for non-invasive transcutaneous neuromodulation as a therapeutic strategy for visceral inflammatory conditions like asthma. For biohackers and clinicians, it suggests that external sensory stimulation, potentially via devices targeting the auricular vagus nerve, could offer a drug-free or adjunctive approach to manage chronic airway inflammation. The identification of CGRPβ as a key mediator provides a specific target for future interventions, potentially leading to more refined protocols. This finding could lead to novel, non-pharmacological interventions for allergic airway inflammation, leveraging the body's intrinsic neuroimmune regulatory circuits.
auricular vagus nerve
airway inflammation
allergic asthma
neuromodulation
trpc1
cgrp